🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: 5ARI

Found 13 matching trials

Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence

N/A

Patient-based surveys will be conducted to evaluate the drivers of medicati...

Status

Completed

Location

Multiple Locations

Start Date

2009-05

Trial ID

NCT01390870

Treatments Being Tested

5ARI or AB or Combination Therapy (5ARI + AB)

Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia

PHASE4

Benign prostatic hyperplasia (BPH) is a common condition among aging men th...

Status

Completed

Location

Beni-Suef University Hospital

Start Date

TBD

Trial ID

NCT07715448

Treatments Being Tested

Tamsulosin Tadalafil 5-Alpha Reductase Inhibitor

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

PHASE4

This study is designed to investigate the comparison between alpha blocker ...

Status

Completed

Location

Samsung Medical Center

Start Date

2011-01

Trial ID

NCT01301599

Treatments Being Tested

combination therapy alpha blocker monotherapy 5 alpha reductase inhibitor monotherapy

Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

N/A

This retrospective study aims to assess the economic impact of early initia...

Status

Completed

Location

Multiple Locations

Start Date

2009-11

Trial ID

NCT01332435

Treatments Being Tested

5ARI + AB

Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

N/A

In patients with benign prostatic hyperplasia (BPH), combination therapy wi...

Status

Completed

Location

Multiple Locations

Start Date

2010-08

Trial ID

NCT01435954

Treatments Being Tested

Early combination therapy Delayed combination therapy

Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia

N/A

This retrospective study aims to quantify the relationship between 5-alpha-...

Status

Completed

Location

Multiple Locations

Start Date

2010-04

Trial ID

NCT01334723

Treatments Being Tested

Adherent with 5-alpha-reductase inhibitor (5ARI) therapy Non-adherent to 5ARI therapy

Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database

N/A

Adherence and length of treatment with a 5-alpha reductase inhibitor (5ARI)...

Status

Completed

Location

Multiple Locations

Start Date

2010-10

Trial ID

NCT01376258

Treatments Being Tested

5ARI

Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan

N/A

This retrospective study aims to assess treatment patterns within 1 year of...

Status

Completed

Location

Multiple Locations

Start Date

2010-04

Trial ID

NCT01323998

Treatments Being Tested

5ARI AB

5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression

N/A

In December 2015, Health Canada issued a warning about a potential relation...

Status

Completed

Location

Multiple Locations

Start Date

2003-01

Trial ID

NCT02876757

Treatments Being Tested

5ARI

Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

N/A

Adherence and length of therapy with 5-alpha reductase inhibitor (5ARI) tre...

Status

Completed

Location

Multiple Locations

Start Date

2010-06

Trial ID

NCT01381510

Treatments Being Tested

5-alpha Reductase Inhibitor (5ARI)

Previous Next